Literature DB >> 33288899

Calculating the economic burden of presumed microbial keratitis admissions at a tertiary referral centre in the UK.

George Moussa1,2, James Hodson3, Nick Gooch4, Jasvir Virdee1,2, Cristina Penaloza4, Jesse Kigozi4, Saaeha Rauz5,6.   

Abstract

PURPOSE: Microbial keratitis (MK) is the most common non-surgical ophthalmic emergency admission in the UK. However, few prospective health-economic studies of MK have been performed, and no specific healthcare resources group (HRG) code exists. This study is designed to determine the feasibility of a data collection tool derived from the microbiology ophthalmology group (MOG) clinical record form, to enable quantification of direct costs of inpatient care, as well as prospective capture of epidemiological data relating to outcomes of MK.
METHODS: Clinical, demographic and economic data were collected retrospectively between January and December 2013 for 101 consecutive patients admitted with MK, using an adaption of the MOG toolset. The direct cost of admission (COA) was calculated using national reference costs and compared to actual income to generate profit/deficit profiles for individual patients. Indices of multiple deprivation were used to assess effect of deprivation on the COA.
RESULTS: The total income generated through discharge coding was £252,116, compared to a COA of £357,075, yielding a deficit of £104,960 (median: £754 per patient). The cost deficit increased significantly with length of stay (LOS, p < 0.001), whilst patients with short LOS were income generators; cost neutrality occurred at 4.8 days. Greater socioeconomic deprivation was also associated with a significantly higher cost deficit.
CONCLUSION: LOS is the key driver for COA of care for MK admissions. Protocols should encourage discharge of patients who are able to self-administer treatment after the sterilisation phase. The MOG-derived data collection toolset captures pertinent clinical data for quantification of COA. Further development into a multiuser and multisite platform is required for robust prospective testing, together with expansion to capture indirect costs of disease burden, including impact of treatment, visual morbidity and quality of life.
© 2020. The Author(s).

Entities:  

Year:  2020        PMID: 33288899     DOI: 10.1038/s41433-020-01333-9

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  1 in total

1.  Estimated burden of keratitis--United States, 2010.

Authors:  Sarah A Collier; Michael P Gronostaj; Amanda K MacGurn; Jennifer R Cope; Kate L Awsumb; Jonathan S Yoder; Michael J Beach
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-11-14       Impact factor: 17.586

  1 in total
  4 in total

1.  Sustained impact of COVID-19 on primary retinal detachment repair in a tertiary eye hospital from March to December 2020.

Authors:  George Moussa; Muhammed Omar Qadir; Soon Wai Ch'ng; Kim Son Lett; Arijit Mitra; Ajai K Tyagi; Ash Sharma; Walter Andreatta
Journal:  Spektrum Augenheilkd       Date:  2022-05-24

2.  Effect of deprivation and ethnicity on primary macula-on retinal detachment repair success rate and clinical outcomes: A study of 568 patients.

Authors:  George Moussa; Dimitrios Kalogeropoulos; Soon Wai Ch'ng; Kim Son Lett; Arijit Mitra; Ajai K Tyagi; Ash Sharma; Walter Andreatta
Journal:  PLoS One       Date:  2021-11-09       Impact factor: 3.240

3.  Delay in accessing definitive care for patients with microbial keratitis in Nepal.

Authors:  Jeremy J Hoffman; Reena Yadav; Sandip Das Sanyam; Pankaj Chaudhary; Abhishek Roshan; Sanjay K Singh; Sailesh K Mishra; Simon Arunga; Victor H Hu; David Macleod; Astrid Leck; Matthew J Burton
Journal:  Front Med (Lausanne)       Date:  2022-07-22

4.  Public perceptions of eye symptoms and hospital services during the first UK lockdown of the COVID-19 pandemic: a web survey study.

Authors:  Gibran F Butt; James Hodson; Graham R Wallace; Saaeha Rauz; Philip I Murray
Journal:  BMJ Open Ophthalmol       Date:  2021-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.